Open Access
Article
Roles of protein kinase B/Akt in lung cancer
Cheng-Xiong Xu1,Hua Jin1,Ji-Young Shin1,Ji-Eun Kim1,Myung-Haing Cho1
1
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA
DOI: 10.2741/E206 Volume 2 Issue 4, pp.1472-1484
Published: 01 June 2010
(This article belongs to the Special Issue Signaling in cancer and disease)
Abstract

Lung cancer is the leading cause of cancer-related death worldwide and has frequently been associated with over-activated protein kinase B (PKB)/Akt. Akt is a serine/threonine protein kinase that plays an important role in cell growth, proliferation, and survival. Many lines of evidence point to the contribution of deregulated Akt in development or progression of lung cancer. In addition, recent studies have demonstrated that cancer cells defend themselves from therapeutic treatment through activation of pro-survival signals, including the Akt pathway. In this review, we described the way in which the Akt pathway is activated in development and progression of lung cancer, and the way in which deregulated Akt plays a significant role in lung tumorigenesis and resistance to chemo- or radiotherapy. In this review, we also discussed the potential of the Akt pathway as a target of lung cancer therapy.

Share and Cite
Cheng-Xiong Xu, Hua Jin, Ji-Young Shin, Ji-Eun Kim, Myung-Haing Cho. Roles of protein kinase B/Akt in lung cancer. Frontiers in Bioscience-Elite. 2010. 2(4); 1472-1484.